Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancers (TNBC) subtype is an aggressive disease with poor clinical outcome. The only treatment available is surgery followed by chemotherapy or radiotherapy. Programmed death-ligand 1 (PD-L1) is a trans-membrane protein expressed on a wide variety of cells including immune cel...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Mol Sci
Hoofdauteurs: Botti, Gerardo, Collina, Francesca, Scognamiglio, Giosuè, Rao, Federica, Peluso, Valentina, De Cecio, Rossella, Piezzo, Michela, Landi, Gabriella, De Laurentiis, Michelino, Cantile, Monica, Di Bonito, Maurizio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2017
Onderwerpen:
Communication
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343992/
https://ncbi.nlm.nih.gov/pubmed/28230773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18020459
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items